How do varying cannabinoid concentrations in commercial products affect consumer safety?
How do varying cannabinoid concentrations in commercial products affect consumer safety? Varying cannabinoid concentrations in commercial products can significantly affect consumer safety by influencing dosing accuracy and potential adverse effects. Inconsistent labeling and variability in cannabinoid content can lead to unexpected psychoactive effects or inadequate symptom relief for consumers, especially those using cannabinoids for therapeutic purposes. Additionally, higher concentrations of THC may increase the risk of negative side effects, such as anxiety or psychosis, particularly in inexperienced users. Regulatory oversight is crucial to ensure that products are accurately labeled and tested for cannabinoid content to protect consumers and enhance the safety of cannabinoid products. Ongoing efforts to standardize cannabinoid concentrations and improve product quality are necessary for consumer safety (Mäkelä et al., 2021).